Overall, patients on omega-3 supplements had an 8% lower risk of total mortality or hospitalization for cardiovascular disease over 4 years.
Study documents higher risks even when creatinine increases are less than 30%, the guideline-recommended threshold for stopping treatment.
Blood pressure targets below 130/80 and below 140/90 mm Hg are associated with similar renal outcomes among non-diabetics, meta-analysis shows.
People with high blood pressure consumed an average of 2,900 mg of sodium per day in 1999 and 3350 mg per day in 2012, for an overall average daily sodium intake of 3100 mg.
Changes over time in prescription adherence are common and affect treatment estimates considerably.
Numerous population studies demonstrate a relationship between higher dietary K+ and lower blood pressure regardless of sodium intake.
Among the etiologies of readmission, cardiac causes including heart failure and coronary artery disease were most common.
With dietitian counseling, limiting sodium to 2000 mg per daily is feasible for chronic kidney disease patients.
Adjusted rates of hospitalization for AF increased by almost 1% per year between 1999 and 2013.
In the United States, more than 92.1 million people have cardiovascular disease.
An estimated 12.3% of Americans over the age of 21 have masked hypertension.
New guidelines suggest aiming for a systolic pressure less than 150 mm Hg in hypertensive individuals aged 60 or older.
With respect to mortality and hospitalizations, there were no significant interactions for β-blockers and pattern or burden of AF.
To receive top ratings, a diet has to be relatively easy to follow, nutritious, safe, effective for weight loss, and protective against diabetes and heart disease.
United States, China, India, Indonesia, and Russia accounted for more than 50% of elevated or high blood pressure cases.
Clinically important heterogeneity in intensive BP treatment remains undetectable in conventional trial designs but can be detected in sequential randomization trial designs.
Spironolactone use was associated with 12% decreased odds of prostate cancer in male patients and 19% decreased odds of bladder cancer in female patients.
Using beta-blockers was also associated with a higher risk of patient's reduced ability to perform daily functions independently.
The DASH diet lowered serum uric acid, and this effect was greater among participants with hyperuricemia.
Nearly a third of hypertensive participants were not adherent to antihypertensive drug therapy.
Conditions such as chronic illness, mental illness, or substance abuse commonly overlap with each other and with poverty, which contributes to poor health.
The findings suggest that living in a polluted environment could promote development of hypertension, cardiovascular disease, and stroke.
Lack of association observed in study of hypertensive patients with normal renal function.
According to the authors, the influence of midlife hypetertension may lead to late-life impaired cognitive function.
Blacks have increased incidence of hypertension, diabetes mellitus, dyslipidemia, but not a-fib.
Findings support modest reductions in sodium intake among persons consuming high-sodium diets
Increased SBP variability tied to mortality, coronary heart disease, stroke, end-stage renal disease
Data from 21 observational studies showed an 8% increased risk of prostate cancer.
Losartan treatment is linked to aldosterone reductions in patients with hypertension but not obstructive sleep apnea.
Findings indicate high-risk adults would benefit from intensive program to lower SBP to 120 or less.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)